Pierre Gravier
DirectoratPTC Therapeutics· In proxies 2023–2025
Pay in FY2024-19% from the year before · PTC Therapeutics stock +63.8% the same year
Pierre Gravier was paid $2.2M in FY2024 (Dec), down 19%. PTC Therapeutics stock rose 63.8% that year.
Pay$100 in the stock at the end of FY22 → $118
Experience
- Filana TherapeuticsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- PTC TherapeuticsPublic company · 3 yr
- Chief Financial Officer2023 – Present · 3 yrStock in role +79%
Roles come from the proxy statements of each company.
Boards1
- Filana TherapeuticsDirector · 2 yr on the boardIndependent—Paid as an executive
Board seats come from each company's latest proxy statement.
Activity
Two people shown as one, or a wrong number?